Table 4.
Magnitude of change in Hct status of the children
| Indicators Hct Study group |
Mean Baseline mean | End line mean ANOVA(1 SE) |
Magnitude of change | P-value |
|---|---|---|---|---|
| SCSB | 0.646 ± 0.1 | 4.126 ± 0.31 | 19.067 (0.2) | 0.001* |
| CSB | 0.691 ± 0.1 | 1.241 ± 0.14 | 8.12 (0.4) | 0.410 |
| Placebo | 0.650 ± 0.1 | 0.181 ± 0.33 | -12.9 (0.4) | 0.656 |
| Baseline | End line | DID (95% CI) | P-value | |
| difference | Difference | |||
| Mean of SCSB minus mean of CSB | −0.005 | 2.885 | 3.775 | 0.001* |
| Mean of SCSB minus mean of Placebo | −0.004 | 3.945 | 4.835 | 0.0001* |
| Mean of CSB minus mean of placebo | 0.001 | 1.06 | 0.106 | 0.088 |
| RR(95%CI) | Z statistics | P-value | ||
| SCSB n = 4 Vs CSB n = 55 | 3.15 (1.91–2.07) | 8.12 | 0.002* | |
| SCSB n = 4 Vs placebo n = 64 | 4.07 (3.63–3.76) | 12.45 | 0.0001* | |
| CSB n = 55 Vs placebo n = 64 | 1.77 (1.68–1.76) | 4.61 | 0.182 | |
| Placebo n = 64 (86.5%) | 1 | |||
| X2-Log-rank (95%CI) | P-value | |||
| SCSB Vs CSB | 0.978 (0.954–1.033) | 0.001* | ||
| SCSB Vs placebo | 0.971 (0.943–0.984) | 0.0001* | ||
| CSB Vs Placebo | 1.901 (0.881–0.933) | 0.701 | ||
| Placebo | 1 | |||
| Mean recovery time in days (CI) | P-value | |||
| SCSBVs CSB | 8 (7–12) | 0.002* | ||
| SCSB Vs placebo | 19 (20–23) | 0.001* | ||
| CSB Vs Placebo | 33 (31–35) | 0.002* | ||
| Placebo | 1 |
a 1SE: Type 1 Standard Error
b *: Significant at P < 0.05